Intravacc announces positive preclinical data for its SARS-CoV-2 nose spray vaccine
- Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2
- Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2